The international use of the boston type i keratoprosthesis

International Ophthalmology Clinics

Volumn 53, Issue 2, 2013, Pages 79-89

  Kim, Michelle J ^a   Bakhtiari, Pejman ^a   Aldave, Anthony J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIRIDIA; ARTICLE; BOSTON TYPE I KERATOPROSTHESIS; CHEMICAL INJURY; CORNEA NECROSIS; CORNEA TRANSPLANTATION; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; ENDOPHTHALMITIS; GLAUCOMA; GRAFT FAILURE; HEALTH CARE COST; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; KERATITIS; KERATOPROSTHESIS; ORGAN DONOR; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA DETACHMENT; SKIN DEFECT; SURGICAL TRAINING; SYSTEMATIC REVIEW; TREATMENT INDICATION; VISUAL ACUITY;

BOSTON; CORNEA; CORNEAL OPACITY; HUMANS; INTERNATIONALITY; PROSTHESES AND IMPLANTS; VISUAL ACUITY;

EID: 84875179425     PISSN: 00208167     EISSN: 15369617     Source Type: Journal    
DOI: 10.1097/IIO.0b013e31827ab3d3     Document Type: Article

References (24)

1. World Health Organization. Visual impairment and blindness. Fact Sheet No 282. Geneva, Switzerland: World Health Organization; June 2012. Available at: http:// www.who.int/mediacentre/factsheets/fs282/en.
2. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79:214-221.
3. Oliveira L, Cade F, Dohlman C. Keratoprosthesis in the fight against corneal blindness in developing countries. Arq Bras Oftalmol. 2011;74:5-6.
4. Bersudsky V, Blum-Hareuveni T, Rehany U, et al. The profile of repeated corneal transplantation. Ophthalmology. 2001;108:461-469.
5. Coster DJ, Williams KA. The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am J Ophthalmol. 2005;140:1112-1122.
6. Fasolo A, Capuzzo C, Fornea M, et al. Risk factors for graft failure after penetrating keratoplasty: 5-year follow-up from the corneal transplant epidemiological study. Cornea. 2011;30:1328-1335.
7. Niederkorn JY, Larkin DF. Immune privilege of corneal allografts. Ocul Immunol Inflamm. 2010;18:162-171.
8. Aldave AJ, Kamal KM, Vo RC, et al. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116:640-651.
9. Traish AS, Chodosh J. Expanding application of the Boston type I keratoprosthesis due to advances in design and improved post-operative therapeutic strategies. Semin Ophthalmol. 2010;25:239-243.
10. Harissi-Dagher M, Beyer J, Dohlman CH. The role of soft contact lenses as an adjunct to the Boston keratoprosthesis. Int Ophthalmol Clin. 2008;48:43-51.
11. Harissi-Dagher M, Khan BF, Schaumberg DA, et al. Importance of nutrition to corneal grafts when used as a carrier of the Boston keratoprosthesis. Cornea. 2007;26:564-568.
12. Zerbe BL, Belin MW, Ciolino JB. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology. 2006;113:e1-e7.
13. Aldave AJ, Sangwan VS, Basu S, et al. International results with the Boston type I keratoprosthesis. Ophthalmology. 2012;119:1530-1538.
14. Al Arfaj K, Hantera M. Short-term visual outcomes of Boston keratoprosthesis type I in Saudi Arabia. Middle East Afr J Ophthalmol. 2012;19:88-92.
15. Robert MC, Harissi-Dagher M. Boston type 1 keratoprosthesis: the CHUM experience. Can J Ophthalmol. 2011;46:164-168.
16. Shihadeh WA, Mohidat HM. Outcomes of the Boston keratoprosthesis in Jordan. Middle East Afr J Ophthalmol. 2012;19:97-100.
17. Verdejo-Gomez L, Pelaez N, Gris O, et al. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety. Ophthalmic Surg Lasers Imaging. 2011;42:446-452.
18. Ament JD, Todani A, Pineda R II, et al. Global corneal blindness and the Boston keratoprosthesis type I. Am J Ophthalmol. 2010;149:537-539.
19. Ament JD, Stryjewski TP, Ciolino JB, et al. Cost-effectiveness of the Boston keratoprosthesis. Am J Ophthalmol. 2010;149:221-228. e2.
20. Pineda R. Introducing new technology with an eye on sustainability. Advanced Ocular Care. 2012;3:60-62.
21. Ament JD, Tilahun Y, Mudawi E, et al. Role for ipsilateral autologous corneas as a carrier for the Boston keratoprosthesis: the Africa experience. Arch Ophthalmol. 2010;128:795-797.
22. Akpek EK, Aldave AJ, Aquavella JV. The use of precut, gamma-irradiated corneal lenticules in Boston type 1 keratoprosthesis implantation. Am J Ophthalmol. 2012;154:495-498. e1.
23. Robert MC, Biernacki K, Harissi-Dagher M. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers. Cornea. 2012;31:339-345.
24. Walcott-Harris R, Chodosh J, Dohlman C. Boston KPro News. Fall 2011, Number 8. Available from: Massachusetts Eye and Ear Infirmary, Boston, MA. Accessed August 27, 2012.